Dr. George Chrysant, MD
Claim this profileIntegris Baptist Medical Center
Studies Aortic Valve Stenosis
Studies Mitral Regurgitation
5 reported clinical trials
11 drugs studied
Affiliated Hospitals
Clinical Trials George Chrysant, MD is currently running
Transcatheter Valve Repair
for Mitral Regurgitation
This trial tests a new device called Edwards PASCAL that fixes leaky heart valves without surgery. It is for patients who can't have surgery or haven't improved with other treatments. The device helps the valve close better, stopping blood from leaking backward.
Recruiting1 award N/A9 criteria
TAVR
for Aortic Stenosis
Obtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, AS.
Recruiting1 award N/A3 criteria
More about George Chrysant, MD
Clinical Trial Related6 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments George Chrysant, MD has experience with
- Edwards PASCAL System
- Abbott Mitraclip System
- Optimal Medical Therapy
- Evolut FX TAVR System
- Medtronic Evolut PRO+ TAVR System
- ACURATE Neo2™ Transfemoral TAVR System
Breakdown of trials George Chrysant, MD has run
Aortic Valve Stenosis
Mitral Regurgitation
Mitral Valve Disease
Mitral Valve Regurgitation
Tricuspid Regurgitation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does George Chrysant, MD specialize in?
Is George Chrysant, MD currently recruiting for clinical trials?
Are there any treatments that George Chrysant, MD has studied deeply?
What is the best way to schedule an appointment with George Chrysant, MD?
What is the office address of George Chrysant, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.